 controversy heparin therapy adjunct acute myocardial infarction Heparin US adjunct therapy prevention reocclusion thrombolysis acute myocardial infarction review literature controversy efficacy heparin thrombolysis beneficial lack beneficial effects heparin pathophysiologic viewpoint need full heparinization postlytic period residual stenosis thrombogenic optimal dose time mode heparin therapy lack definitive data reasonable intravenous heparin thrombolytic therapy partial thromboplastin time times control concurrent antiplatelet agent aspirin recommendations consistent consensus opinion American College Cardiology American Heart Association